These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31287582)

  • 1. Effects of levosimendan in heart failure: The role of echocardiography.
    Cameli M; Incampo E; Navarri R; Mandoli GE; Sciaccaluga C; Righini FM; Palmerini E; Sisti N; Mondillo S; Lunghetti S
    Echocardiography; 2019 Aug; 36(8):1566-1572. PubMed ID: 31287582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure.
    Yilmaz MB; Yontar C; Erdem A; Karadas F; Yalta K; Turgut OO; Yilmaz A; Tandogan I
    Heart Vessels; 2009 Jan; 24(1):16-21. PubMed ID: 19165563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Levosimendan on Ventricular Systolic and Diastolic Functions in Heart Failure Patients: A Meta-Analysis of Randomized Controlled Trials.
    Long YX; Cui DY; Kuang X; Hu S; Hu Y; Liu ZZ
    J Cardiovasc Pharmacol; 2021 Jun; 77(6):805-813. PubMed ID: 34001722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene.
    Hillestad V; Kramer F; Golz S; Knorr A; Andersson KB; Christensen G
    J Appl Physiol (1985); 2013 Nov; 115(10):1572-80. PubMed ID: 24072410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Levosimendan on cardiac function, size and strain in heart failure patients.
    Beitzke D; Gremmel F; Senn D; Laggner R; Kammerlander A; Wielandner A; Nolz R; Hülsmann M; Loewe C
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):1063-1071. PubMed ID: 33103224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
    Oner E; Erturk M; Birant A; Kurtar Mansıroglu A; Akturk IF; Karakurt H; Yalcin AA; Uzun F; Somuncu MU; Yildirim A
    Cardiol J; 2015; 22(1):87-93. PubMed ID: 24846511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of levosimendan without loading dose on systolic and diastolic function in patients with end-stage heart failure.
    Lunghetti S; Palmerini E; Urselli R; Maffei S; Guarino E; Focardi M; Mondillo S; Favilli R
    Cardiol J; 2011; 18(5):532-7. PubMed ID: 21947989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levosimendan Can Improve the Level of B-Type Natriuretic Peptide and the Left Ventricular Ejection Fraction of Patients with Advanced Heart Failure: A Meta-analysis of Randomized Controlled Trials.
    Cui D; Liao Y; Li G; Chen Y
    Am J Cardiovasc Drugs; 2021 Jan; 21(1):73-81. PubMed ID: 32462455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of levosimendan on ventriculo-arterial coupling and cardiac efficiency in paediatric patients with single-ventricle physiology after surgical palliation: retrospective study.
    Iacobelli R; Ricci Z; Marinari E; Haiberger R; Di Molfetta A; Toscano A; Di Chiara L
    Interact Cardiovasc Thorac Surg; 2020 Apr; 30(4):623-629. PubMed ID: 31986196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inotropic and lusitropic effects of levosimendan and milrinone assessed by strain echocardiography-A randomised trial.
    Fredholm M; Jörgensen K; Houltz E; Ricksten SE
    Acta Anaesthesiol Scand; 2018 Oct; 62(9):1246-1254. PubMed ID: 29926912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systolic mitral annulus velocity is a sensitive index for changes in left ventricular systolic function during inotropic therapy in patients with acute heart failure.
    Husebye T; Eritsland J; Bjørnerheim R; Andersen GØ
    Eur Heart J Acute Cardiovasc Care; 2018 Jun; 7(4):321-329. PubMed ID: 28045338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of levosimendan in elderly patients with severe heart failure].
    Wang YB; Yu YH; Gong SJ; Yan J; Wang Y
    Zhonghua Nei Ke Za Zhi; 2020 Jun; 59(6):433-438. PubMed ID: 32486583
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of levosimendan on ventricular remodelling in patients with left ventricular systolic dysfunction: a meta-analysis.
    Wang X; Zhao XZ; Wang XW; Cao LY; Lu B; Wang ZH; Zhang W; Ti Y; Zhong M
    ESC Heart Fail; 2024 Jun; 11(3):1352-1376. PubMed ID: 38419326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure.
    Branzi G; Malfatto G; Villani A; Ciambellotti F; Revera M; Giglio A; Rosa FD; Facchini M; Parati G
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):662-8. PubMed ID: 20613551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].
    Prijić S; Rakić S; Nikolić L; Jovicić B; Stajević M; Vukomanović V; Kosutić J
    Vojnosanit Pregl; 2011 Nov; 68(11):979-84. PubMed ID: 22191317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term effects of levosimendan on strain/strain rate markers in patients with nonischemic dilated cardiomyopathy.
    Kırış T; Avcı E
    J Clin Ultrasound; 2018 Oct; 46(8):527-532. PubMed ID: 30229927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications.
    Altenberger J; Gustafsson F; Harjola VP; Karason K; Kindgen-Milles D; Kivikko M; Malfatto G; Papp Z; Parissis J; Pollesello P; Pölzl G; Tschöpe C
    J Cardiovasc Pharmacol; 2018 Mar; 71(3):129-136. PubMed ID: 28817484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of ventriculo-arterial coupling in ST elevation myocardial infarction with left ventricular dysfunction treated with levosimendan.
    Trambaiolo P; Bertini P; Borrelli N; Poli M; Romano S; Ferraiuolo G; Penco M; Guarracino F
    Int J Cardiol; 2019 Aug; 288():1-4. PubMed ID: 31056414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Blinded Study of the Left Ventricular Myocardial Performance Index Comparing Epinephrine to Levosimendan following Cardiopulmonary Bypass.
    Salgado Filho MF; Barral M; Barrucand L; Cavalcanti IL; Verçosa N
    PLoS One; 2015; 10(12):e0143315. PubMed ID: 26655803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effectiveness and Safety of Intermittent, Repeated, or Continuous Use of Levosimendan, Milrinone, or Dobutamine in Patients With Advanced Heart Failure: A Network and Single-Arm Meta-analysis.
    Zhang X; Wang Z; Zhang L; Zhao X; Han Y
    J Cardiovasc Pharmacol; 2024 Jul; 84(1):92-100. PubMed ID: 38547524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.